• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Re-Evaluation of Efficacy of Moderate-Intensity Statins in Korean Patients with Type 2 Diabetes Mellitus.

作者信息

Kim Soo Kyoung

机构信息

Department of Internal Medicine and Institute of Health Sciences, Gyeongsang National University Hospital, Gyeongsang National University School of Medicine, Jinju, Korea.

出版信息

Diabetes Metab J. 2017 Feb;41(1):20-22. doi: 10.4093/dmj.2017.41.1.20.

DOI:10.4093/dmj.2017.41.1.20
PMID:28236382
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5328692/
Abstract
摘要

相似文献

1
Re-Evaluation of Efficacy of Moderate-Intensity Statins in Korean Patients with Type 2 Diabetes Mellitus.韩国2型糖尿病患者中高强度他汀类药物疗效的重新评估
Diabetes Metab J. 2017 Feb;41(1):20-22. doi: 10.4093/dmj.2017.41.1.20.
2
Letter: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).信函：中等强度他汀类药物对韩国2型糖尿病患者血脂异常的治疗效果（《糖尿病代谢杂志》2017年；第41卷：第23 - 30页）
Diabetes Metab J. 2017 Apr;41(2):150-151. doi: 10.4093/dmj.2017.41.2.150.
3
Response: Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2017;41:23-30).回应：中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效（《糖尿病代谢杂志》2017年；41:23 - 30）
Diabetes Metab J. 2017 Apr;41(2):152-153. doi: 10.4093/dmj.2017.41.2.152.
4
Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.心肌梗死老年患者使用大剂量和中等剂量他汀类药物治疗时的糖尿病与心血管事件
Circ Cardiovasc Qual Outcomes. 2013 May 1;6(3):315-22. doi: 10.1161/CIRCOUTCOMES.111.000015. Epub 2013 May 14.
5
Putting the diabetes risk due to statins in perspective: a re-evaluation using the complementary outcome.从互补结果重新评估他汀类药物导致糖尿病的风险：
Nutr Metab Cardiovasc Dis. 2014 Jul;24(7):705-8. doi: 10.1016/j.numecd.2014.02.012. Epub 2014 Mar 1.
6
Effects of high intensity interval training versus moderate intensity continuous training on the reduction of oxidative stress in type 2 diabetic adult patients: CAT.高强度间歇训练与中等强度持续训练对2型糖尿病成年患者氧化应激降低的影响：过氧化氢酶
Medwave. 2015 Aug 13;15(7):e6212. doi: 10.5867/medwave.2015.07.6212.
7
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.与其他他汀类药物相比，瑞舒伐他汀降低糖尿病患者低密度脂蛋白胆固醇的有效性及达到美国国家胆固醇教育计划成人治疗小组第三次指南低密度脂蛋白胆固醇目标的情况：一项使用美国电子病历数据集的回顾性研究
Curr Med Res Opin. 2007 Sep;23(9):2125-33. doi: 10.1185/030079907X219580.
8
REVIEW: Efficacy and mechanisms of action of statins in the treatment of diabetic dyslipidemia.综述：他汀类药物治疗糖尿病血脂异常的疗效及作用机制
J Clin Endocrinol Metab. 2006 Feb;91(2):383-92. doi: 10.1210/jc.2005-2084. Epub 2005 Nov 15.
9
Statins and diabetes risk: how real is it and what are the mechanisms?他汀类药物与糖尿病风险：真实情况如何以及机制是什么？
Curr Opin Lipidol. 2015 Jun;26(3):228-35. doi: 10.1097/MOL.0000000000000172.
10
Efficacy and safety of statins in the treatment of diabetic dyslipidemia.他汀类药物治疗糖尿病血脂异常的疗效与安全性。
Tunis Med. 2010 Feb;88(2):80-4.

引用本文的文献

1
Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.韩国心血管疾病和糖尿病高危患者的低密度脂蛋白胆固醇目标达标率：一项回顾性队列研究。
Lipids Health Dis. 2020 Jan 11;19(1):5. doi: 10.1186/s12944-019-1158-5.
2
Efficacy and safety of alirocumab in Korean patients with hypercholesterolemia and high cardiovascular risk: subanalysis of the ODYSSEY-KT study.在高胆固醇血症和高心血管风险的韩国患者中，阿利西尤单抗的疗效和安全性：ODYSSEY-KT 研究的亚组分析。
Korean J Intern Med. 2019 Nov;34(6):1252-1262. doi: 10.3904/kjim.2018.133. Epub 2018 Sep 1.

本文引用的文献

1
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.中等强度他汀类药物治疗韩国2型糖尿病患者血脂异常的疗效
Diabetes Metab J. 2017 Feb;41(1):23-30. doi: 10.4093/dmj.2017.41.1.23. Epub 2016 Dec 16.
2
Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.瑞舒伐他汀在美国居住的白种人和亚洲人群中的药代动力学与药物遗传学
Eur J Clin Pharmacol. 2015 Mar;71(3):329-40. doi: 10.1007/s00228-014-1800-0. Epub 2015 Jan 30.
3
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2013年美国心脏病学会/美国心脏协会成人降低动脉粥样硬化性心血管风险的血胆固醇治疗指南：美国心脏病学会/美国心脏协会实践指南工作组报告
Circulation. 2014 Jun 24;129(25 Suppl 2):S1-45. doi: 10.1161/01.cir.0000437738.63853.7a. Epub 2013 Nov 12.
4
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.瑞舒伐他汀预防C反应蛋白升高的男性和女性发生血管事件。
N Engl J Med. 2008 Nov 20;359(21):2195-207. doi: 10.1056/NEJMoa0807646. Epub 2008 Nov 9.
5
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial.日本普伐他汀预防心血管疾病的一级预防（MEGA研究）：一项前瞻性随机对照试验。
Lancet. 2006 Sep 30;368(9542):1155-63. doi: 10.1016/S0140-6736(06)69472-5.
6
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.居住在同一环境中的白种人和亚洲受试者中瑞舒伐他汀的药代动力学和药物遗传学。
Clin Pharmacol Ther. 2005 Oct;78(4):330-41. doi: 10.1016/j.clpt.2005.06.013.
7
Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.东亚人和高加索人在药物药代动力学上的差异以及基因多态性的作用。
J Clin Pharmacol. 2004 Oct;44(10):1083-105. doi: 10.1177/0091270004268128.
8
Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.瑞舒伐他汀在日本高胆固醇血症患者中的随机剂量反应研究。
J Atheroscler Thromb. 2003;10(6):329-36. doi: 10.5551/jat.10.329.
9
Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials.他汀类药物治疗高胆固醇血症：随机双盲试验中血脂变化的剂量特异性荟萃分析。
BMC Fam Pract. 2003 Dec 1;4:18. doi: 10.1186/1471-2296-4-18.
10
Sustained reduction of serum cholesterol in low-dose 6-year simvastatin treatment with minimum side effects in 51,321 Japanese hypercholesterolemic patients.在51321名日本高胆固醇血症患者中，低剂量辛伐他汀进行6年治疗可持续降低血清胆固醇，且副作用最小。
Circ J. 2003 Apr;67(4):287-94. doi: 10.1253/circj.67.287.